Aurora B kinase inhibitor AZD II52: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancerAZZARITI, A; BOCCI, G; DEL BUFALO, D et al.British journal of cancer. 2011, Vol 104, Num 5, pp 769-780, issn 0007-0920, 12 p.Article

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinibBOCCI, G; FALCONE, A; DEL TACCA, M et al.British journal of cancer. 2008, Vol 98, Num 10, pp 1619-1629, issn 0007-0920, 11 p.Article

Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in miceINNOCENTI, F; DANESI, R; DI PAOLO, A et al.Drug metabolism and disposition. 1995, Vol 23, Num 7, pp 713-717, issn 0090-9556Article

Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluationBOCCI, G; TUCCORI, M; EMMENEGGER, U et al.Annals of oncology. 2005, Vol 16, Num 8, pp 1243-1252, issn 0923-7534, 10 p.Article

An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasmaFOGLI, S; DANESI, R; INNOCENTI, F et al.Therapeutic drug monitoring. 1999, Vol 21, Num 3, pp 367-375, issn 0163-4356Article

Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995)DANESI, R; AGEN, C; BENELLI, U et al.Clinical cancer research. 1997, Vol 3, Num 2, pp 265-272, issn 1078-0432Article

Vascular endothelial i growth factor and interleukin-8 in ovarian cystic pathologyFASCIANI, A; D'AMBROGIO, G; BOCCI, G et al.Fertility and sterility. 2001, Vol 75, Num 6, pp 1218-1221, issn 0015-0282Article

Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patientsBOCCI, G; DANESI, R; DEL TACCA, M et al.Clinical cancer research. 2000, Vol 6, Num 8, pp 3032-3037, issn 1078-0432Article

Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivoBOCCI, G; DANESI, R; BENELLI, U et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, Num 3, pp 205-212, issn 0344-5704Article

Pharmacogenetics in oncologyDANESI, R; DI PAOLO, A; BOCCI, G et al.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 14, pp 74-78, issn 1359-6349, 5 p.Conference Paper

In vitro antiangiogenic activity of selective somatostatin subtype-I receptor agonistsBOCCI, G; CULLER, M. D; FIORAVANTI, A et al.European journal of clinical investigation. 2007, Vol 37, Num 9, pp 700-708, issn 0014-2972, 9 p.Article

An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipientsVANNOZZI, F; FILIPPONI, F; DI PAOLO, A et al.Transplantation proceedings. 2004, Vol 36, Num 9, pp 2787-2790, issn 0041-1345, 4 p.Article

Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patientsDI PAOLO, A; DANESI, R; DEL TACCA, M et al.Annals of oncology. 2001, Vol 12, Num 9, pp 1301-1306, issn 0923-7534Article

VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamideORLANDI, P; FONTANA, A; FRANCIA, G et al.British journal of cancer. 2013, Vol 109, Num 4, pp 957-964, issn 0007-0920, 8 p.Article

A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancerFORNARO, Lorenzo; MASI, G; DEL TACCA, M et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 5, pp 965-969, issn 0344-5704, 5 p.Article

Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case reportBOCCI, G; DANESI, R; ALLEGRINI, G et al.European journal of clinical pharmacology. 2002, Vol 58, Num 9, pp 593-595, issn 0031-6970, 3 p.Article

Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity : Implications for drug monitoring in children with acute lymphoblastic leukemiaINNOCENTI, F; DANESI, R; CASAZZA, G et al.Therapeutic drug monitoring. 2000, Vol 22, Num 4, pp 375-382, issn 0163-4356Article

High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomataFASCIANI, A; D'AMBROGIO, G; BOCCI, G et al.Molecular human reproduction. 2000, Vol 6, Num 1, pp 50-54, issn 1360-9947Article

Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexateINNOCENTI, F; DANESI, R; DI PAOLO, A et al.Cancer chemotherapy and pharmacology. 1996, Vol 37, Num 5, pp 409-414, issn 0344-5704Article

Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancerLOUPAKIS, F; CREMOLINI, C; DI PAOLO, A et al.British journal of cancer. 2011, Vol 104, Num 8, pp 1262-1269, issn 0007-0920, 8 p.Article

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patientsALLEGRINI, G; FALCONE, A; DANESI, R et al.British journal of cancer. 2008, Vol 98, Num 8, pp 1312-1319, issn 0007-0920, 8 p.Article

Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cellsBOCCI, G; FIORAVANTI, A; ORLANDI, P et al.British journal of cancer. 2005, Vol 93, Num 3, pp 319-330, issn 0007-0920, 12 p.Article

Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cellsDI PAOLO, A; DANESI, R; NARDINI, D et al.British journal of cancer. 2000, Vol 82, Num 4, pp 905-912, issn 0007-0920Article

Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimensINNOCENTI, F; DANESI, R; BOCCI, G et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, Num 2, pp 133-140, issn 0344-5704Article

The heparan sulfate Suleparoide inhibits rat corneal angiogenesis and in vitro neovascularizationBENELLI, U; BOCCI, G; NARDI, M et al.Experimental eye research. 1998, Vol 67, Num 2, pp 133-142, issn 0014-4835Article